The Latest: Hong Kong to resume use of BioNTech-Pfizer shots
Hong Kong will resume administering the coronavirus vaccine developed by Pfizer and BioNTech on Monday following a 12-day suspension over packaging defects detected in one batch |!…
Hong Kong will resume administering the coronavirus vaccine developed by Pfizer and BioNTech on Monday following a 12-day suspension over packaging defects detected in one batch |!…